Irish Medical Equipment Stock News

For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly...

Why Ryanair Holdings (ISE:RYA) is on investors’ radar today Ryanair Holdings (ISE:RYA) has drawn fresh attention after recent share price moves, with the stock showing a 1 day decline of 0.8% and a 4% drop over the past week. See our latest analysis for Ryanair Holdings. While the recent 1 day and 7 day share price returns show a pullback, Ryanair Holdings is still sitting on a strong 1 year total shareholder return of 42.51% and a 5 year total shareholder return of 88.06%. As a result, the...

If you are wondering whether Kerry Group at €77.00 is starting to look like value, you are not alone, especially given how far the share price has come over recent years. The stock has returned 2.9% over the last 7 days and 4.8% over the last 30 days, yet it is still showing a 1% gain year to date and a 20% decline over the past year, with 3 year and 5 year returns of 5.9% and 24.6% declines respectively. These moves have come as investors continue to reassess long term expectations for...

What recent performance tells you about Kerry Group Kerry Group (ISE:KRZ) has drawn attention after a mixed run in its share price, with a small 1 day decline alongside gains over the past week and month, but weaker returns over the past year. Over the past year, the stock shows a total return decline of about 20%, and the past 3 years and 5 years are also negative. In contrast, the past week and month are positive, while the past 3 months are slightly negative. On the fundamentals side,...

If you are wondering whether Glanbia’s current share price offers good value, it helps to look at how that price lines up with the fundamentals rather than just the headline moves. The stock most recently closed at €16.62, with returns of 1.8% over 7 days, 14.0% over 30 days, 14.8% year to date, 21.0% over 1 year, 60.5% over 3 years and 89.7% over 5 years. This may shape how you think about both upside and risk. Recent coverage around Glanbia has focused on its position within the food,...

Key Insights Significant control over Glanbia by retail investors implies that the general public has more power to...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...

Uniphar plc ( ISE:UPR ), is not the largest company out there, but it received a lot of attention from a substantial...

Key Insights The projected fair value for Kerry Group is €140 based on 2 Stage Free Cash Flow to Equity Kerry Group is...

Glenveagh Properties (ISE:GVR) has put two clear signals on the table: a new share buyback of up to €25 million and guidance to scale homebuilding output to about 2,000 units by 2027. See our latest analysis for Glenveagh Properties. Those capital return and growth plans come after a solid stretch of gains, with the share price at €2.01 and a 90 day share price return of 10.93%. The 1 year total shareholder return sits at 30.52% and the 5 year total shareholder return is 136.47%, suggesting...

Quite a few insiders have dramatically grown their holdings in Glanbia plc ( ISE:GL9 ) over the past 12 months. An...

Kingspan Group (ISE:KRX) has had a rough month with its share price down 4.2%. However, a closer look at its sound...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

As the pan-European STOXX Europe 600 Index reaches new heights, buoyed by an improving economic backdrop and marking its strongest yearly performance since 2021, investors are increasingly focusing on small-cap opportunities within this dynamic market landscape. In such a thriving environment, identifying stocks with strong fundamentals and insider activity can highlight potential undervalued opportunities in the European small-cap sector.

Ryanair Holdings plc ( ISE:RYA ) is reducing its dividend from last year's comparable payment to €0.193 on the 25th of...

Zevra Therapeutics announced that it has entered into an exclusive expanded access distribution agreement with Ireland-based Uniphar, enabling Niemann-Pick Disease Type C patients in select territories outside Europe to obtain reimbursed named-patient supply of MIPLYFFA, the only approved therapy that targets the underlying pathology of this ultra-rare condition. The deal strengthens Uniphar’s position as a specialist partner for complex rare-disease logistics, highlighting its capabilities...

Key Insights Institutions' substantial holdings in Bank of Ireland Group implies that they have significant influence...

With a price-to-earnings (or "P/E") ratio of 19.9x Kingspan Group plc ( ISE:KRX ) may be sending bearish signals at the...

It is hard to get excited after looking at Kerry Group's (ISE:KRZ) recent performance, when its stock has declined 3.4...

With a price-to-earnings (or "P/E") ratio of 34x Glanbia plc ( ISE:GL9 ) may be sending very bearish signals at the...

Key Insights Kingspan Group's estimated fair value is €80.95 based on 2 Stage Free Cash Flow to Equity Kingspan Group's...

Key Insights The considerable ownership by retail investors in Uniphar indicates that they collectively have a greater...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...